KREBSBIO

Krebs Biochemicals & Industries Share Price

₹75.26 -0.95 (-1.25%)

Stock Result Declared

21 May, 2025 00:07

SIP TrendupStart SIP in KREBSBIO

Start SIP

Performance

  • Low
  • ₹75
  • High
  • ₹80
  • 52 Week Low
  • ₹61
  • 52 Week High
  • ₹129
  • Open Price₹77
  • Previous Close₹76
  • Volume15,011

Investment Returns

  • Over 1 Month -2.6%
  • Over 3 Month -12.44%
  • Over 6 Month -9.43%
  • Over 1 Year + 10.35%
SIP Lightning

Smart Investing Starts Here Start SIP with Krebs Biochemicals & Industries for Steady Growth!

Invest Now

Krebs Biochemicals & Industries Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -6
  • PEG Ratio
  • 0.2
  • Market Cap Cr
  • 162
  • P/B Ratio
  • -1.4
  • Average True Range
  • 4.55
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.45
  • RSI
  • 49.04
  • MFI
  • 43.28

Krebs Biochemicals & Industries Financials

Krebs Biochemicals & Industries Technicals

EMA & SMA

Current Price
₹75.26
-0.95 (-1.25%)
pointer
  • stock-down_img
  • Bearish Moving Average 15
  • stock-up_img
  • Bullish Moving Average 1
  • 20 Day
  • ₹75.37
  • 50 Day
  • ₹77.49
  • 100 Day
  • ₹81.30
  • 200 Day
  • ₹83.11

Resistance and Support

76.67 Pivot Speed
  • R3 83.09
  • R2 81.42
  • R1 78.34
  • S1 73.59
  • S2 71.92
  • S3 68.84

What's your outlook on Krebs Biochemicals & Industries?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Krebs Biocs.& Inds. has an operating revenue of Rs. 49.18 Cr. on a trailing 12-month basis. An annual revenue de-growth of -4% needs improvement, Pre-tax margin of -39% needs improvement, ROE of 0% is poor and needs improvement. NULL The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 10 which is a POOR score indicating inconsistency in earnings, a RS Rating of 45 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 76 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Krebs Biochemicals & Industries Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-05-20 Audited Results
2025-02-04 Quarterly Results & Others To Consider Other business matters.
2024-11-11 Quarterly Results & Other To Consider Other business matters.
2024-08-07 Quarterly Results
2024-05-21 Audited Results

Krebs Biochemicals & Industries F&O

Krebs Biochemicals & Industries Shareholding Pattern

72.74%
0.5%
20.42%
6.34%

About Krebs Biochemicals & Industries

  • NSE Symbol
  • KREBSBIO
  • BSE Symbol
  • 524518
  • Managing Director & CEO
  • Mr. Jitendra Shah
  • ISIN
  • INE268B01013

Similar Stocks to Krebs Biochemicals & Industries

Krebs Biochemicals & Industries FAQs

Krebs Biochemicals & Industries share price is ₹75 As on 20 May, 2025 | 23:53

The Market Cap of Krebs Biochemicals & Industries is ₹162.3 Cr As on 20 May, 2025 | 23:53

The P/E ratio of Krebs Biochemicals & Industries is -6 As on 20 May, 2025 | 23:53

The PB ratio of Krebs Biochemicals & Industries is -1.4 As on 20 May, 2025 | 23:53

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23